CTOs on the Move

Jaguar Health

www.jaguar.health

 
Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.jaguar.health
  • 201 Mission Street Suite 2375
    San Francisco, CA USA 94105
  • Phone: 415.371.8300

Executives

Name Title Contact Details

Funding

Jaguar Health raised $15M on 01/13/2021
Jaguar Health raised $10.8M on 04/29/2021

Similar Companies

Rodeo Dental & Orthodontics

Rodeo Dental & Orthodontics has 100+ dental experts from several specialties! Your one-stop shopping in STYLE for all your oral health needs.

Ananda Professional

Ananda Professional is a company that provides premium Full Spectrum CBD products, including tinctures, softgels, and topicals, to independent pharmacies nationwide.

Medsite

Medsite is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EPIC Behavioral Healthcare

...your behavioral health specialty care provider

Shire

At Shire, we enable people with life altering conditions to lead better lives. We focus on developing and delivering innovative treatments for patients with rare diseases and other specialty conditions.To realize our aspiration to become a leading global biotech, our efforts are concentrated on four key strategic drivers: growth, innovation, efficiency, and people. Our priorities are to drive optimal performance of our existing products, increase patient access to these medicines, and to build our pipeline through research and development and partnerships in order to deliver new medicines to patients.